221 related articles for article (PubMed ID: 17484067)
1. Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study.
Ray LA; Miranda R; Kahler CW; Leventhal AM; Monti PM; Swift R; Hutchison KE
Psychopharmacology (Berl); 2007 Sep; 193(4):449-56. PubMed ID: 17484067
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers.
Green R; Bujarski S; Lim AC; Venegas A; Ray LA
Exp Clin Psychopharmacol; 2019 Jun; 27(3):257-264. PubMed ID: 30628813
[TBL] [Abstract][Full Text] [Related]
3. Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial.
King A; Cao D; Zhang L; Rueger SY
Addiction; 2013 Oct; 108(10):1836-44. PubMed ID: 23714324
[TBL] [Abstract][Full Text] [Related]
4. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
Ray LA; Hutchison KE
Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
[TBL] [Abstract][Full Text] [Related]
5. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.
Fridberg DJ; Cao D; Grant JE; King AC
Alcohol Clin Exp Res; 2014 Oct; 38(10):2622-9. PubMed ID: 25335648
[TBL] [Abstract][Full Text] [Related]
6. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.
Ray LA; Courtney KE; Ghahremani DG; Miotto K; Brody A; London ED
Psychopharmacology (Berl); 2014 Oct; 231(19):3843-53. PubMed ID: 24733235
[TBL] [Abstract][Full Text] [Related]
7. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
Lim AC; Roche DJO; Ray LA
J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
[TBL] [Abstract][Full Text] [Related]
8. Influence of the A118G Polymorphism of the OPRM1 Gene and Exon 3 VNTR Polymorphism of the DRD4 Gene on Cigarette Craving After Alcohol Administration.
Lechner WV; Knopik VS; McGeary JE; Spillane NS; Tidey JW; McKee SA; Metrik J; Leventhal AM; Rohsenow DJ; Kahler CW
Nicotine Tob Res; 2016 May; 18(5):632-6. PubMed ID: 26092968
[TBL] [Abstract][Full Text] [Related]
9. A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.
Kahler CW; Cioe PA; Tzilos GK; Spillane NS; Leggio L; Ramsey SE; Brown RA; O'Malley SS
Alcohol Clin Exp Res; 2017 Jun; 41(6):1201-1211. PubMed ID: 28401564
[TBL] [Abstract][Full Text] [Related]
10. Effects of naltrexone during the descending limb of the blood alcohol curve.
Ray LA; Hutchison KE; MacKillop J; Miranda R; Audette A; Swift R; Monti PM
Am J Addict; 2008; 17(4):257-64. PubMed ID: 18612879
[TBL] [Abstract][Full Text] [Related]
11. Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedure.
Kruse MI; Radnovich AJ; Kalapatapu RK; Mehdiyoun N; Chambers RA; Davidson D
J Stud Alcohol Drugs; 2012 Mar; 73(2):205-15. PubMed ID: 22333328
[TBL] [Abstract][Full Text] [Related]
12. Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study.
Bujarski S; MacKillop J; Ray LA
Exp Clin Psychopharmacol; 2012 Jun; 20(3):181-90. PubMed ID: 22429255
[TBL] [Abstract][Full Text] [Related]
13. Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study.
Roberts W; Shi JM; Tetrault JM; McKee SA
J Addict Med; 2018; 12(3):227-233. PubMed ID: 29438157
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study.
Ray LA; Bujarski S; Chin PF; Miotto K
Neuropsychopharmacology; 2012 Jan; 37(2):445-55. PubMed ID: 21900886
[TBL] [Abstract][Full Text] [Related]
15. Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.
Ray LA; Courtney KE; Ghahremani DG; Miotto K; Brody A; London ED
Am J Drug Alcohol Abuse; 2015 Jan; 41(1):35-44. PubMed ID: 24949564
[TBL] [Abstract][Full Text] [Related]
16. Within- and between-person effects of naltrexone on the subjective response to alcohol and craving: A daily diary investigation.
Waddell JT; Corbin WR; MacKinnon DP; Leeman RF; DeMartini KS; Fucito LM; Kranzler HR; O'Malley SS
Alcohol Clin Exp Res; 2022 Mar; 46(3):477-491. PubMed ID: 35076087
[TBL] [Abstract][Full Text] [Related]
17. Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.
Hendershot CS; Wardell JD; Samokhvalov AV; Rehm J
Addict Biol; 2017 Nov; 22(6):1515-1527. PubMed ID: 27411969
[TBL] [Abstract][Full Text] [Related]
18. Sex-dependent effects of alcohol administration on the urge to use cannabis.
Venegas A; Meredith LR; Green R; Cooper ZD; Ray LA
Exp Clin Psychopharmacol; 2021 Dec; 29(6):689-695. PubMed ID: 32658530
[TBL] [Abstract][Full Text] [Related]
19. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial.
Ray LA; Green R; Roche DJO; Bujarski S; Hartwell EE; Lim AC; Rohrbaugh T; Ghahremani D; Hutchison K; Miotto K
Alcohol Clin Exp Res; 2018 Mar; 42(3):613-623. PubMed ID: 29265379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
